First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report. ASAIO J • May 31, 2020
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. ASAIO J • May 1, 2020
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J • April 23, 2020
Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the time of COVID-19 pandemic. ASAIO J • April 19, 2020
First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO – a case report. ASAIO J • April 19, 2020
Trends in Extracorporeal Membrane Oxygenation Growth in the United States, 2011-2014. ASAIO J • September 25, 2018
Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J • May 12, 2015
Accidental cannulation of the left ascending lumbar vein through femoral access-still often unrecognized. ASAIO J • November 8, 2012
Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation. ASAIO J • September 15, 2008